Protara Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Protara Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $412.00K, a 5050.00% increase year-over-year.
- Protara Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $13.00K.
- Protara Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $8.00K, a 94.07% decline year-over-year.
- Protara Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $135.00K.
- Protara Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $21.00K, a 84.44% decline from fiscal 2024.
- Protara Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $135.00K.
- Protara Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $530.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $412.00K 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $21.00K 10-K · filed 2026-03-10 | |
| 2025-09-30 | $13.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $8.00K 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $135.00K 10-K · filed 2026-03-10 | |
| 2024-06-30 | $135.00K 10-Q · filed 2025-11-10 | |
| 2020-12-31 | $530.00K 10-K · filed 2022-03-09 | |
| 2020-09-30 | $530.00K 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |